Skip to main content

Table 2 Observed MACE rates stratified by GP IIIa polymorphism

From: Effect of PlA1/A2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stenting

 

A1A1

n = 690

A1A2

n = 248

A2A2

n = 25

p

MACE %

13.6

14.1

8.0

0.730

Death %

4.8

8.1

0.0

0.083

Revascularisation

    

   PCI %

15.7

4.1

8.0

0.522

   CABG %

2.8

3.6

4.0

0.822

Unstable angina %

1.7

4.0

4.2

0.095

Acute MI %

0.6

0.4

0.0

1.000

  1. CABG, coronary artery bypass graft; MACE, major adverse coronary event; MI, myocardial infarction; PCI, percutaneous coronary intervention.